Status:
COMPLETED
Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Ischemic Colitis
Eligibility:
All Genders
18+ years
Brief Summary
Our objective is to determine a prognostic score including CT, clinical and biological criteria predicting the serious (death / surgery) or non-serious (medical treatment) evolution of ischemic coliti...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age \> or = at 18 years old;
- Performing an abdomino-pelvic scan injected within 6 hours of the onset of symptoms;
- Ischemic colitis proven by endoscopy or surgical data.
- Exclusion criteria:
- CT scan performed without injection and / or after 6 hours following the onset of symptoms;
- Unproven ischemic colitis.
Exclusion
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT04662268
Start Date
January 1 2014
End Date
November 30 2020
Last Update
December 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295